 Clue number one is, in 2003, for a brief period, it was the largest stock in the S&P 500. Number two, unlike many of its competitors, it took no initial research fund from the United States Operation Warp Speed vaccine development program, instead choosing to invest roughly $2 billion of its own funds in a COVID vaccine. Number three, the company was established in 1849 in New York by two German entrepreneurs...